| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | Acteurs de La French Care [Automatic translation follows] The grouping of actors who support and develop the health ecosystem in France! The grouping of actors who support and develop the health ecosystem in France! Type: | 35 | 5 | 33 | 1 |
 |  Xerago B2B Building Predictable, Cost-Optimal Revenue Engines for B2B Enterprises At Xerago B2B, we empower mid-market and enterprise B2B companies to achieve sustainable growth through our unique approach to Digital Impact. Our comprehensive solutions span Consulting, Projects, and Digital as a Service, focusing on Data, Experiences, Technology, and Campaigns and Commerce. We help our clients optimize targeting, streamline operations, and enhance customer experiences, ensuring predictable revenue and long-term success. Join us in transforming digital initiatives into powerful engines for growth and customer satisfaction. Type: | 36 | 0 | 36 | 555 |
 |  Mauna Kea Technologies The real-time in vivo cellular imaging platform that revolutionizes the way physicians diagnose and treat patients. Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real-time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio platform is used globally across a wide range of medical specialties and is revolutionizing the way physicians diagnose and treat patients — making a transformative … Type: | 3 | 1 | 2 | 122 |
 | Abingworth Life Science Investing Abingworth is a leading transatlantic life sciences investment firm. Abingworth helps transform cutting-edge science into novel medicines by providing capital and expertise to top caliber management teams building world-class companies. Since 1973, Abingworth has invested in over 180 life science companies, leading to 46 M&As and 70+ IPOs. Our therapeutic focused investments fall into three categories: seed and early-stage, development stage, and clinical co-development. Abingworth supports its portfolio companies with a team of experienced professionals at offices in London, Menlo Park (California), and Boston. Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022. Investing in … Type: | 7 | 3 | 5 | 44 |
 | Drug Discovery World The Global Business Review of Drug Discovery and Development Welcome to our LinkedIn page. This is where we will share original content from the DDW team and industry experts, as well as daily news and other company updates. Published for over 20 years, DDW is the only truly global business review of all aspects of drug discovery and development and has firmly established itself as a highly respected and ‘must read’ journal within the discovery and development arena. DDW is renowned for voicing the opinions of some of the Industry’s leading luminaries and has become a recognised ‘platform’ for ‘Industry … Type: | 20 | 3 | 18 | 8 |
 | Biotalys Transforming crop protection We are a rapidly growing and transformative crop protection company developing a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Based on our ground-breaking technology platform, Biotalys is developing a broad pipeline of effective and safe products with novel modes of action, addressing key crop pests and diseases across the whole value chain, from soil to plate. Biotalys’ unique protein-based biocontrols aim to combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. We are … Type: | 8 | 3 | 7 | 69 |
 | RefleXion Medical SCINTIX biology-guided radiotherapy is now FDA cleared. SCINTIX biology-guided radiotherapy now FDA cleared. SCINTIX® therapy detects and responds to signals emitted from the cancer itself and, for the first time, uses them to deliver immediate treatment for tumors in the lung or bone that may arise from primary or metastatic disease. cancer care, radiation therapy, life sciences, medical devices, biotechnology, oncology, manufacturing, PET scanner, electrical engineering, product engineering, algorithms engineer, new product development, and software engineering Type: | 2 | 2 | 1 | 248 |
 | Inspirna, Inc. Converting cancer to a manageable, chronic condition Inspirna, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancers of high unmet need. Inspirna’s lead drug candidate, ompenaclid (RGX-202), is an orally-administered small molecule that targets the CKB/SLC6A8 pathway, which when activated enables the generation of ATP in response to tumor hypoxia. Ompenaclid is currently being tested in multiple mid-stage clinical trials in patients with advanced or metastatic RAS mutant colorectal cancer. Inspirna’s second clinical stage drug candidate, abequolixron (RGX-104), is an oral small molecule activator of LXR/APOE … Type: | 2 | 2 | 0 | 35 |
 | Artios Taking control of the DNA Damage Response (DDR) Artios is on a mission to kill cancer by exploiting DNA damage response (DDR) and repair pathways that are leveraged by cancer cells to promote their survival. Our specialized DcoDeR platform integrates Artios’ leadership capabilities, expertise and experience in DNA damage biology and drug discovery to systematically discover and develop medicines targeting the totality of the DDR. We have built an extensive DDR focused pipeline designed to address areas of high unmet needs across solid tumour indications including our ATR inhibitor, ART0380, and our Polθ inhibitor ART6043, as monotherapy and combination treatments. … Type: | 7 | 3 | 0 | 116 |
 | ProQR Therapeutics Advancing our proprietary AxiomerTM RNA-editing platform technology Changing lives is what drives us at ProQR Therapeutics. We are advancing our proprietary AxiomerTM RNA-editing platform technology. Our highly energetic team strives to combine innovative technologies and entrepreneurism to make a meaningful impact on the lives of individuals and the people around them. If you are up to this challenge and like to be part of our team, check out our website for vacancies: http://www.proqr.com/careers/ RNA therapeutics, Drug development, Rare Diseases, Genetic Diseases, Orphan drugs, Pharmaceuticals, and RNA editing Type: | 3 | 3 | 1 | 173 |
 | Octarine Bio We're harnessing nature to drive sustainable solutions Pioneering new sustainable bio-based ingredients Synthetic Biology, Fermentation, Yeast metabolism, Plant metabolism, and Metabolic engineering Type: | 1 | 1 | 0 | 25 |
 | ImmuONE Specialised translational approaches and in vitro testing services ImmuONE specialises in human alveolar macrophage responses, epithelial cell culture platforms and testing services. Our respiratory tissue models closely resemble lung physiology to provide relevant, reliable, and reproducible results. ImmuONE is partnered with the industry and academia to develop sustainable technologies for the future to support human-relevant, mechanistic driven safety assessments and develop animal product-free cell models. We offer a range of standard and bespoke assessments for inhalation safety assessment needs. ImmuONE provides innovative solutions for inhalation toxicology, irritation sensitization, alveolar clearance, inflammation and can tailor to your inhalation safety assessment needs. … Type: | 4 | 0 | 2 | 15 |
 | AstronauTx AstronauTx is tackling dementia through improving brain physiology AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both improve symptoms and modify disease. Type: | 2 | 0 | 1 | 11 |
 | Redmile Group Redmile Group is a company based out of San Francisco. Type: | 2 | 2 | 0 | 72 |
 | MATWIN French Accelerator dedicated to innovation in oncology MATWIN (Maturation & Accelerating Translation With INdustry) est un programme accélérateur pour développer la recherche translationnelle en cancérologie et faciliter le transfert des innovations vers les patients. Son objectif principal est d'accompagner des projets innovants (issus de laboratoires académiques ou portés par des startups) et présentant un fort potentiel de développement en favorisant des partenariats précoces. Le programme s’appuie sur un partenariat avec de grands laboratoires engagés en oncologie (Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Exact Sciences, Gilead, GlaxoSmithKline, Nanostring Technologies, Novartis, Pfizer, Pierre Fabre, Roche, Sanofi) et l’ensemble des acteurs soucieux de … Type: | 58 | 8 | 52 | 7 |
 | BioCorteX We believe that everyone - irrespective of who they are or where they live - deserve medications that work We believe that everyone - irrespective of who they are or where they live - deserve medications that work Type: | 1 | 1 | 0 | 15 |
 | BIOWEG Revolutionizing the Future of Bio-ingredients BIOWEG, founded in 2019 in Germany, is a purpose-driven organization powered by conscious ChemDesign. We match Bio-innovation to business problems. We explore and combine biotechnology, material science, and molecular simulation learning to create advanced sustainable bio-based high-performance ingredients. Our ingredients are 100% animal free, globally scalable, and sustainably produced without harsh chemicals. We work with results-oriented, forward-thinking companies, and consumer brands with global scale in the cosmetics, personal care, nutraceuticals, agricultural coatings, and food/beverage sectors who desire highly differentiated and sustainable science-based ingredient technologies. Material Science, Fermentation , Green Chemistry, Alternative Ingredients, Biobased Materials, Biodegradabe, … Type: | 24 | 3 | 2 | 21 |
 | Fast Company Inspiring the future of business. Fast Company is the world’s leading business media brand, with an editorial focus on innovation in technology, leadership, world changing ideas, creativity, and design. Written for and about the most progressive business leaders, Fast Company inspires readers to think expansively, lead with purpose, embrace change, and shape the future of business. social media Type: | 93 | 69 | 21 | 3,130 |
 | HarperCollins Publishers Publishing great authors since 1817. HarperCollins Publishers is the second-largest consumer book publisher in the world. Headquartered in New York, HarperCollins has publishing operations in 15 countries. With two hundred years of history and more than 120 branded imprints around the world, HarperCollins publishes approximately 10,000 new books every year in 16 languages, and has a print and digital catalog of more than 200,000 titles. Writing across dozens of genres, HarperCollins authors include winners of the Nobel Prize, the Pulitzer Prize, the National Book Award, the Newbery and Caldecott Medals, and the Man Booker Prize. HarperCollins is a subsidiary of … Type: | 15 | 4 | 11 | 4,167 |
 | NatureWorks A naturally advanced biomaterials company using plants to turn greenhouse gases into IngeoTM️ PLA biopolymers. NatureWorks is an advanced materials company offering a broad portfolio of renewably-sourced polymers and chemicals to the packaging, polymers, fibers, and chemicals markets. With performance and economics that compete with oil-based plastics and fibers, naturally advanced IngeoTM polymers are valued for their unique functional properties and used in products from coffee capsules and electronics to diapers and wipes. Creating performance through chemistry, VercetTM lactide-based solutions help innovators realize significant, measurable performance and cost advantages in products such as C.A.S.E., toners, and surfactants. NatureWorks is jointly … Type: | 10 | 1 | 2 | 212 |
 | Marks & Clerk Leading global network of intellectual property specialists We’re true specialists – focusing on IP and IP alone. With patent attorneys, trade mark attorneys, commercial lawyers and IP litigators, we can provide every type of intellectual property service you need. Our expertise is globally acknowledged - in our top tier status, the awards we’ve won and in the cutting-edge work we do, which helps shape future law. Intellectual property, Litigation, Prosecution, Patents, Trade Marks, Law, Designs, Copyright, Unified Patent Court, and EPO | 3 | 1 | 1 | 594 |
 | Life Extension The Science of a Healthier LifeTM Life Extension® is the health solutions expert that is translating scientific research into everyday insights for people wanting to live their healthiest lives. For almost 40 years, Life Extension® has pursued innovative advances in health, conducting rigorous clinical trials and setting some of the most demanding standards in the industry to offer a full range of quality vitamins and nutritional supplements and blood-testing services. Life Extension’s Wellness Specialists provide personalized counsel to help customers choose the right products for optimal health, nutrition and personal care. Type: | 1 | 1 | 0 | 443 |
 | VERTEXA Digital Therapeutics [Automatic translation follows] VERTEXA is an immersive therapeutic game in virtual reality. Let's digitalize health! The VERTEXA digital therapy (Virtual Reality Therapy Exposition in Anorexia) aims to use virtual reality as a support tool in the form of a gamified and immersive psychoeducational journey for patients suffering from eating disorders (anorexia, bulimia). The use of digital tools and new technologies now allow an innovative, personalized, motivating and accessible approach regardless of where our patients are treated. The VERTEXA tool is intended to be autonomous: the patient is an actor in their care. They will be immersed in a soothing universe, … Type: | 23 | 2 | 23 | 3 |
 | La Gazette du Midi [Automatic translation follows] Follow all the economic news from Toulouse and Haute-Garonne in an instant. La Gazette du Midi is a weekly economic and legal news newspaper headquartered in Toulouse. Created in 1881, the newspaper is authorized to publish judicial and legal announcements in Haute-Garonne. It is part of the ForumEco group. Type: | 93 | 5 | 91 | 8 |
 | AFI Ventures Europe’s Day-One Impact Launchpad At AFI Ventures, we are committed to backing the most promising seed & pre-seed impact entrepreneurs. From climate action to healthy living, we partner with every visionary that shares the ambition of deep, at-scale impact. We are investing up to 500k€ in 1 to 2 companies every month. AFI Ventures is the seed fund of Alliance for Impact, Europe's day one impact launchpad. impactinvesting, capitalrisque, VC, impact, startup, fonds, seed, financement, entrepreneurship, and socialbusiness Type: | 18 | 15 | 4 | 5 |
 | Ulysse Communication [Automatic translation follows] Who better than former journalists to make your voice heard? Ulysse Communication, at the crossroads of press and communication. Specialized in press relations and financial communication, Ulysse Communication was created by former economic and financial journalists who themselves surrounded themselves with former journalists. The agency and the team are strongly marked by this DNA which translates into an intimate knowledge of the media, an ability to develop tailor-made messages and a good understanding of the economic and business world. Press relations, Financial communication, Finance, Listed company, IPO, Financial operations, Public relations, Corporate communication, Asset management, Real estate, … Type: | 52 | 1 | 50 | 14 |
 | Thuja Capital Healthcare Investors Thuja Capital is an early-stage venture capital firm located in Utrecht, The Netherlands. We invest in product focused companies that aim to have true impact for patients and doctors alike, as demonstrated in clinical studies to enable a health claim. Hence most of our ventures are active in the field of therapeutics, medical devices and digital health. Not only do we invest, we also take an active role in helping the company to become successful, by leveraging our extensive network and by bringing our own experience to the table. red biotechnology, life sciences, medical technology, diagnostics, medical devices, … Type: | 10 | 2 | 9 | 18 |
 | Janus Henderson Investors We’re a global asset manager dedicated to investing in a #BrighterFutureTogether for our clients. Janus Henderson’s mission is to help clients define and achieve superior financial outcomes through differentiated insights, disciplined investments and world-class service. We’re dedicated to investing in a brighter future together. Formed in 2017 from the merger between Janus Capital Group and Henderson Global Investors, we have 90 years’ experience in investing, underpinned by a culture deep rooted in research. With over 340 investment professionals worldwide, who meet regularly to share insights, we’re able to offer a world-class service providing tailored solutions and the personal touch of … Type: | 3 | 3 | 0 | 2,960 |
 | baby vc Come for a VC bootcamp, stay for the community. First bootcamp for those who aspire to join the venture capital community. A unique program during which a group of aspiring VCs meet those who make venture capital. They reveal to us behind the scenes, the secrets and the future of their profession. Have a look at our job board juste here: [https://airtable.com/shrePuJCHfJbTq17m/tblsaFTVJnUA2JWuY] Are you a venture capital fund or startup looking for a stellar addition to your team? Then add your job offer via this form [https://airtable.com/shrYcgd6zU6VAKlRL] to get access to our fellows and our community 🤓 venture capital, bootcamp, … Type: | 72 | 4 | 69 | 163 |
 | Cellomatics Biosciences Ltd Our expertise, Your discovery Cellomatics Biosciences Ltd. (www.cellomaticsbio.com) is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology/Immuno-Oncology, Immunology/Inflammation and Respiratory therapeutic areas. Based at Colwick Quays Business Park, Nottingham UK, our experienced scientific team offers bespoke and innovative preclinical in vitro bioassay services to support our client’s drug development programmes. We work with diverse group of global clients including early start-ups, virtual/small to medium sized Biotechnology and Pharmaceutical companies. Multiplex Immunoassay, Target and biomarker validation, In vitro functional assays, Molecular Biology, Receptor binding, Toxicity testing, Immuno-Oncology, Oncology, Immunology, Inflammation, and Respiratory Type: | 1 | 0 | 0 | 18 |
 | TECHNION FRANCE [Automatic translation follows] French representation of the Technion, Israel Institute Of Technology Technion France's mission is to promote the Technion, Israel Institute of Technology, in scientific, industrial and economic circles and to publicize the Technion's achievements and projects in the fields of scientific and technological research. In addition, it intends to foster the establishment of close relationships between these circles and all of the Technion's scientists, teachers and students, for the development of cooperation on projects of common interest. It also aims to increase the number of events and conferences in France by inviting specialist professors from Israel. Finally, it … Type: | 47 | 13 | 32 | 8 |
 | centdegrés Creative Activists Since 1988 We believe in bold creativity. For thirty years, we’ve focused all our energies on helping our clients win their battles, improve their impact, and challenge the status quo. Through design. We hunt down the best conditions for your projects in order to create unique personalised design and make a new kind of impact. Anything that will only achieve a partial result is a waste of time. We live by the certainty that there is no such thing as “hype”, freedom and creativity are crucial aspects of our approach. We have continuously created exceptional experiences, brands, products … | 6 | 2 | 6 | 62 |
 | Motive Partners Investors, Operators, Innovators Motive Partners is a private equity firm with offices in New York City, London, Berlin and Amsterdam, focusing on growth equity and buyout investments in software and information services companies based in North America and Europe and serving five primary subsectors: Banking & Payments, Capital Markets, Data & Analytics, Wealth & Asset Management and Insurance. Motive Partners brings differentiated expertise, connectivity and capabilities to create long-term value in financial technology companies. More information on Motive Partners can be found at www.motivepartners.com Type: | 11 | 2 | 4 | 125 |
 | The Michael J. Fox Foundation for Parkinson's Research Here. Until Parkinson's isn't. The Michael J. Fox Foundation for Parkinson's Research is dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today. Type: | 7 | 1 | 6 | 372 |
 | Abzena Abzena is the leading end-to-end bioconjugate & complex biologics CDMO+CRO, focused on rapidly moving medicines forward. Abzena is the leading end-to-end bioconjugate, ADC, and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, … Type: | 6 | 0 | 0 | 442 |
 | Handelsblatt [Automatic translation follows] Germany's business and financial newspaper / Substance decides. The Handelsblatt is the largest business and financial newspaper in German. Around 200 editors and correspondents worldwide stand for well-founded and independent quality journalism that researches and analyzes national and global topics and events exclusively and up-to-date. With around 40 correspondents abroad, the Handelsblatt is on site in all economic centers of the world. News, business, stock exchange, economic policy, finance, and money Type: | 138 | 82 | 39 | 516 |
 | Esquire magazine The most stylish and substantial men’s magazine. A one-stop shop for lifestyle advice – cars, culture, grooming, gadgets, food, fashion and more – and a showcase for brilliant journalism and photography. Esquire is intelligent, irreverent and unapologetically masculine. Type: | 10 | 8 | 10 | 299 |
 | AudioTelligence Disruptive hearing technology start-up (CLOSED) Situational hearing loss is a huge and growing problem worldwide, affecting over 80% of people over 40. Often called ‘The Cocktail Party Problem’, this means that sufferers can hear speech clearly in quiet rooms, but in noisy situations they find it hard to follow conversations. AudioTelligence’s aisoTM technology can supercharge hearing enhancement on your device. AisoTM goes a step further than other solutions which simply reduce background noise, by isolating and extracting the speech or sound that the user wants to hear from surrounding noise and unwanted sounds. With aisoTM, users can effectively regain their … Type: | 18 | 0 | 16 | 6 |
 | Forbion Impacting the future of medicine Forbion was born out of ABN AMRO Capital Life Sciences in 2000. Six years later, we transitioned to Forbion Capital Partners. Today, to emphasize our value-add beyond merely providing capital, we are simply known as Forbion. For more than two decades, our investment team has built an impressive track record of sourcing, building and guiding life-sciences companies resulting in many breakthrough therapies and valuable exits. Forbion currently manages over €2.3 bn across ten funds. As of October 2022, Forbion holds 43 active portfolio companies bringing its investments to 95 companies to date with 46 employees. … Type: | 8 | 4 | 5 | 62 |
 | LSI Where Medtech executives build lasting businesses. Join us at LSI Europe '24 September 16th - 20th in Sintra, Portugal LSI’s ecosystem provides the intelligence and relationships Medtech leaders need to build breakthrough businesses. We support thousands of innovators, investors, and strategics around the world working to move Medtech forward, together. For nearly two decades, our market intelligence solutions have powered strategic decisions for the world’s most successful Medtech, Life Science, and Healthcare organizations. With that foundation, we launched the LSI Emerging Medtech Summits with one vision: create forums for the leaders building, financing, and scaling Medtech innovation to challenge convention … Type: | 24 | 1 | 24 | 60 |
 | Antler Antler is the investor backing the world’s most driven founders, from day zero to greatness. Founded on the belief that people innovating is the key to building a better future, we partner with people across six continents to launch and scale high-potential startups that address meaningful opportunities and challenges. Knowing that exceptional founders can come from anywhere with any background, we have offices in 30 cities, including Austin, New York, London, Berlin, Stockholm, Bangalore, Jakarta, Portugal, Singapore, Seoul, Spain, Tokyo, and Sydney. Our global community backs people from the beginning with co-founder matching, deep business model validation, initial capital, expansion … Type: | 68 | 38 | 34 | 1,840 |
 | Business Insider What you want to know. Follow us on Facebook, Instagram, YouTube, and TikTok. Visit our homepage for the day's top stories. Type: | 139 | 81 | 59 | 14 |
 | Zambon Since 1906 our mission is innovating Cure & Care to make patients’ lives better. Zambon is a chemical-pharmaceutical company founded on the history and values of an Italian family and committed to innovating cure & care to improve patients’ lives. Present in Europe, America and Asia with over 2,900 employees and manufacturing units in Italy, Switzerland, France, China and Brazil, in 2023 the Group revenues amounted to 899 million euros. Zambon SpA, the pharma subsidiary of the group with its 23 branchess and products commercialized in 87 countries, has taken a new role in the industry. In addition to pain … Type: | 11 | 3 | 6 | 2,470 |
 |  Kymab Ltd Kymab, a Sanofi company, based in Cambridge UK, is working to provide novel solutions in drug and vaccine development. Kymab, a Sanofi company, is a clinical-stage global biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary antibody platform which contains a full diversity of human antibodies, making it the most comprehensive antibody development platform available. Kymab’s platform has been designed to maximise the diversity of human antibodies produced in response to immunisation with antigens. Selecting from a broad diversity of fully human antibodies assures the highest probability of finding drug candidates with … Type: | 1 | 1 | 0 | 39 |
 | Adjuvant Capital Adjuvant Capital is the leading investment fund focused on public health. Adjuvant Capital is a life sciences investment firm focused on global health. We make $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease. Type: | 1 | 0 | 1 | 15 |
 | Numbered We are a design and technology agency crafting beautiful digital experiences and products Contact@numbered.com Numbered is an awards winning creative agency working with fashion, tech & lifestyle brands. We collaborate closely with our clients to tell their stories, engaging audiences by building beautiful experiences & products. Based in Amsterdam & New-york. We strongly believe every brand and project is unique and should be tailor-made from industry leaders to early stage companies. We don’t do one size fits all. Collaborating with international brands, founders, start-ups, venture capitals, and more – producing, results-driven, unique products and experiences from conception to delivery. With … Type: | 3 | 0 | 3 | 37 |
 | Phacilitate Through conferences, community and market insights, we create partnerships that help advance the next pillar of medicine Phacilitate creates an environment where promising innovation can turn into the products that are changing the future of medicine. Recognised as the market leader in providing the life science sector with strategic insight, inspiration and unparalleled business networking, Phacilitate enables professionals to stay abreast of the issues driving life science innovation. #advancedtherapies #biotech #celltherapy #genetherapy Clinical Development, Cell Therapy, Gene Therapy, Oncology, Cancer, Precision Medicine, Biotech, Advanced Therapy, Biotechnology, and Life Sciences Type: | 6 | 1 | 5 | 16 |
 | Pyrowave Electrifying progress. We are leading the revolution in #sustainable #greenchemistry by offering a modular microwave based technology that can #unzip waste plastics back to their root chemical form. Styrene, Polyolefin wax, Lubricants, Microwave, Plastics, #CircularEconomy, #LowCarbonCement , CleanTechnology, #Nanorecycling, GreenSolutions, and #WasteReduction Type: | 5 | 1 | 4 | 11 |
 | Startup Insider [Automatic translation follows] The most important news, trends and investments from the German startup scene. Startup Insider is a new industry portal for the startup scene in Germany, Austria and Switzerland. Here you will find news from all regions and industries as well as an overview of the most important players and events in the German-speaking startup world. The mission of Startup Insider is to support startups on their way to success. We help startups and grownups to establish contacts with investors and customers, to find new employees or through media visibility at events or online, in print or newsletters. … Type: | 36 | 5 | 33 | 39 |
 | Cyber Valley Europe’s largest AI research consortium Cyber Valley is Europe’s largest and leading research consortium in the field of artificial intelligence (AI) and modern robotics. Cyber Valley has a mission and a public mandate to advocate for entrepreneurship, research, development, application, and acceptance of technologies and methods in the field of intelligent systems. The company envisions a future where the full potential of intelligent systems is leveraged for the greater good of the world. The Cyber Valley Community connects partners from science, industry, and society, along with AI researchers and entrepreneurs. The Cyber Valley GmbH is funded by the state of … Type: | 11 | 1 | 7 | 25 |
 | Intermediate Capital Group (ICG) Global alternative asset manager, creating sustainable value by partnering with ambitious businesses. We are a global alternative asset manager with a 35-year track record. We are driven by purpose and sustainable results. We deliver outstanding investment performance to our clients, provide wide‐ranging capital solutions for corporates and owners of real assets, and create value for stakeholders, shareholders and communities. Private Markets, Private Capital, Alternative Asset Management, Private Credit, Private Debt, Secondaries, Structured Products, Real Assets, Infrastructure, Real Estate, and Life Sciences Type: | 9 | 2 | 4 | 778 |
 | Apollo Global Management, Inc. Apollo is a high-growth alternative asset manager. Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade to private equity with a focus on three investing strategies: yield, hybrid, and equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a … Type: | 17 | 4 | 6 | 4,235 |
 | STAT Reporting from the frontiers of health and medicine. Reporting from the frontiers of health and medicine We take you inside the science labs and hospitals, biotech boardrooms and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all. Get access to exclusive content: http://www.statnews.com. Follow us on Twitter @statnews and on Facebook at facebook.com/statnews news, science news, medicine, health, biotech, pharma, health tech, covid, hospitals, and … Type: | 22 | 7 | 12 | 338 |
 | Northzone Northzone is a venture capital fund shaped by lives as entrepreneurs and investors. Founded in 1996. Northzone is a technology investment partnership. With two decades of experience, we have been chosen by some of the best entrepreneurs as their long-term partner for growth. With offices across the Nordics, London and in New York, we work around the clock to connect our companies with customers, business partners and key talent on a truly international scale. As former entrepreneurs ourselves, we have been sat on both sides of the table, and place the relationships with our Founders at the core of our … Type: | 36 | 17 | 24 | 54 |
 | Salesforce Ventures For the most enterprising founders. Salesforce Ventures helps enterprising founders build companies that reinvent the way the world works. Since 2009, we’ve invested in and partnered with more than 400 of the world's most tenacious enterprise software companies from seed to IPO, including Airtable, Databricks, DocuSign, Guild Education, Hopin, monday.com, nCino, Snowflake, Snyk, Stripe, Tanium, and Zoom. Salesforce Ventures leverages our decades of expertise in the cloud and our long-term relationships with key decision-makers at thousands of businesses around the world to give our portfolio companies an unfair advantage, help them build credibility, and accelerate growth. Cloud Computing, SaaS, Enterprise … Type: | 10 | 4 | 4 | 63 |
 | Owkin We use AI to find the right treatment for every patient. Owkin is an AI biotechnology company that uses AI to find the right treatment for every patient. We combine the best of human and artificial intelligence to answer the research questions shared by biopharma and academic researchers. By closing the translational gap between complex biology and new treatments, we bring new diagnostics and drugs to patients sooner. We use AI to identify new treatments, de-risk and accelerate clinical trials and build diagnostic tools. Using federated learning, a pioneering collaborative AI framework, Owkin enables partners to unlock valuable insights from … Type: | 34 | 14 | 22 | 466 |
 | Syncona Limited Building the next generation of healthcare companies Syncona, is a leading FTSE 250 healthcare company focused on creating, building and scaling a portfolio of global leaders in life science. Our vision is to build a sustainable, diverse portfolio of 20- 25 companies focused on delivering transformational treatments to patients in truly innovative areas of healthcare, through which we are seeking to deliver strong risk-adjusted returns for shareholders. We take a long-term view, underpinned by a strategic capital base which enables us to maintain significant ownership positions in our companies and provides us with control and flexibility over the management of … Type: | 9 | 3 | 1 | 52 |
 | BIOKET Bioeconomy Key Enabling Technologies platform Process & Technology innovations for biobased solutions to food, feed, chemicals, biomaterials and bioenergies Brussels, BELGIUM -- May 11-13, 2025 -- Biomass is a wonderful ressource to be transformed into chemicals, biobased materials, food and feed ingredients or energy. Still, adaptation and optimisation of transformation processes and technologies is a real challenge in order to valorise all biomass fraction in a circular approach. In the context of Industry 4.0, the circular economy and the need for an optimal valorization of renewable resources, BIOKET is the only European conference dedicated to bio-based technologies and processes. Innovative Processes, Biotechnology, Green Chemistry, Polymerisation, … Type: | 35 | 9 | 29 | 2 |
 | Panakes Partners Life Sciences dedicated VC firm Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world, in two funds. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250 million under management. Panakes brings strong entrepreneurial and financial expertise to portfolio companies well beyond just capital, relying on a wide network of clinicians and industry experts. We have established relationships with selected industrial partners to assist our … Type: | 12 | 2 | 7 | 18 |
 | Myricx Bio Developing a new class of ADCs based on NMT inhibition to treat cancer We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer. Type: | 2 | 1 | 1 | 13 |
 | Silicon Valley Bank Silicon Valley Bank (SVB), a division of First Citizens Bank, is the bank of the world’s most innovative companies and investors. SVB provides commercial and private banking to individuals and companies in the technology, life science and healthcare, private equity, venture capital and premium wine industries. SVB operates in centers of innovation throughout the United States, serving the unique needs of its dynamic clients with deep sector expertise, insights and connections. SVB's parent company, First Citizens Bancshares, Inc. (NASDAQ: FCNCA) is a top 20 U.S. financial institution with more than $200 billion in assets. First Citizens Bank, Member FDIC. Learn … Type: | 113 | 40 | 32 | 5,153 |
 | Parkinson's UK We’ll find a cure. Together. Powered by people. Funded by you. Improving life for everyone affected by Parkinson’s. Your mum, colleague or friend. Anyone can get Parkinson’s, young or old. Every hour, two more people are diagnosed. Unlocking new treatments means delving into the causes of Parkinson’s. That’s why we fund the Parkinson's UK Brain Bank – the world's only brain bank dedicated to Parkinson's research. Over 10,000 people have donated their brains to help scientists around the world to unravel the mysteries of the condition and develop better treatments. The largest charitable funder of Parkinson’s research in Europe, we’re … Type: | 1 | 0 | 0 | 614 |
 | Wellcome Sanger Institute The Wellcome Sanger Institute is a world leading genomics research centre. The Wellcome Sanger Institute is a world leader in genomics research. We generate and analyse data at a scale not easily possible elsewhere. We apply and explore genomic technologies to advance the understanding of biology and improve health. Our ambition is vast – we take on projects that are not possible anywhere else. We use the power of genome sequencing to understand and harness the information in DNA. Funded by Wellcome, we have the freedom and support to push the boundaries of genomics. Our findings are used to improve … Type: | 6 | 4 | 2 | 1,430 |
 | BioCentury Inc. BioCentury gives biopharma executives, investors and institutions the power to make business-critical decisions through independent, deep-dive analysis; high-quality data; and industry-leading business intelligence, and global events. When you subscribe to BioCentury, our team of Ph.D.s, analysts and industry experts become an extension of your team, helping you answer critical questions, decipher strategic trends, objectively evaluate product and business strategies, and assess competitive, financial, and policy risks. We also help you to build your network by connecting you the who’s who in the industry. Watch the latest episodes of The BioCentury Show on YouTube www.biocenturyyoutube.com Subscribe to the "BioCentury This Week" … Type: | 11 | 4 | 8 | 73 |
 | Parc Científic de Barcelona [Automatic translation follows] Where Science becomes Business Located in the knowledge campus, the PCB provides you with basic ordinary services and a privileged environment for networking. More than 2,700 highly qualified researchers work at the PCB; join our community! | 5 | 2 | 3 | 109 |
 | United Ventures We support visionary entrepreneurs to reinvent industries through technology. At United Ventures we look for daring entrepreneurs willing to develop innovative products and technologies, who acknowledge the challenges and risks of our times and still crave to come out on top in business. As entrepreneurs ourselves, our mission is to spot winners and drive them to achieve success and worldwide recognition through our mentorship, financial and business development support. With a long-standing track record of both start-up and scale-up technological companies, we can boast the industry expertise, mentorship and business networking that it takes to create a success story. Thanks … Type: | 20 | 2 | 14 | 57 |
 | Triple Ring Technologies A trusted partner in bringing technology to life. Triple Ring Technologies is a co-development company headquartered in Silicon Valley, with offices in Boston, Toronto, and Copenhagen. We partner with clients in medtech, life sciences, and sustainability & the environment to create new technologies, launch innovative projects, and start new ventures. Our capabilities span early R&D, product development, manufacturing, regulatory approval, market access, strategic investment, and incubation. For more information, please visit www.tripleringtech.com. For inquiries, please email info@tripleringtech.com. Advanced Research & Development - applied to commercial problems, Innovation Programs, Medical Device Design, Prototyping, Modeling, Validation, Product Development / Design, Grant Funded … Type: | 4 | 0 | 4 | 111 |
 | Intuitive Ventures Accelerating the future of minimally invasive care. Intuitive Ventures is the venture capital arm of Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, Calif. Through its inaugural $100 million fund, Intuitive Ventures invests in and is advancing the digital, device, therapeutic and diagnostic ecosystems of minimally invasive care and beyond, fostering a disciplined and sustainable investment platform that will offer strategic and financial returns for the long term. Building on Intuitive's entrepreneurial beginnings as a medtech and healthcare success story in Silicon Valley, and as a digitally native company, Intuitive Ventures is well-positioned to identify and support early-stage innovators meeting that challenge. … Type: | 5 | 1 | 3 | 6 |
 | Merck At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and … Type: | 17 | 16 | 0 | 41,521 |
 | StartupItalia #SIOS24 Florence, 2/10 a Firenze #SIOS24 Winter, 17/12 a Milano Biglietti Early bird qui: su startupitaliaopensummit.eu We are now ready to take the next step to create a launchpad with significant impact on the creation of new startups in Italy. Platform with data from startups, innovative companies, investors and skilled people. Educational platform to support mindset building and training for a future generation of entrepreneurs with clear vertical specializations. Services and support for a new generation of startups with appropriate growth models Flexible space to bring together the ecosystem and support flexible expansions for startups and Corporates/SMEs. "The largest Italian … Tags: H2020 Type: | 56 | 16 | 37 | 94 |
 | Ship2B Ventures Investing for a Better World We are a venture capital firm that invests in the best impact startups. Inversión, Inversión de Impacto, Inversión en startups, Inversión en salud, Inversión en medio ambiente, Inversión en educación, Impact Investment, Health, HealthCare, Climate Change, Sustainability, Education, Venture Capital, Private Equity, and Fondo de inversión Type: | 16 | 3 | 8 | 20 |
 | Medicines Discovery Catapult Reshaping drug discovery for patient benefit. Independent, not-for-profit national innovation centre for drug discovery. We collaborate with UK medicines discovery and diagnostics organisations, giving them access to industry-leading expertise, cutting-edge technology, and high-quality data. We accelerate their progress, precision drugs get to clinical trials more rapidly, and patients get life-improving medicines earlier than they otherwise would have. biotechnology, pharma, medicines discovery, biotech, informatics, pharmaceuticals, drug discovery, tissue samples, discovery science and technology, virtual research and development, mass spectrometry, complex cell models, clinical data, biomarkers, tissue imaging, drug delivery, target engagement, target validation, omics, and drug research Type: | 9 | 2 | 6 | 201 |
 | Labiotech.eu The leading digital media covering global biotech innovation Labiotech.eu is the leading digital media covering the global biotech industry. Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Join them now and enjoy reading our stories! "We are building the Next Generation of Digital Media for Biotech" Philip & Joachim, Founders of Labiotech.eu Biotechnology, Life science, News, and Media Type: | 28 | 3 | 25 | 12 |
 | Evaluate Ltd Evaluate provides trusted commercial intelligence and predictive analytics to the pharmaceutical industry Evaluate provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global pharmaceutical market to drive better decisions. Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action: Evaluate Omnium - provides a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, delivering game-changing insight into pharma asset potential. EvaluatePharma - the trusted global view of the … Type: | 7 | 1 | 5 | 197 |
 | Life Science Leader Connect. Collaborate. Contribute. Life Science Leader magazine is an essential business journal for life science executives who work for everything from emerging biotechs to Big Pharmas. Our content is designed to inform readers of industry best practices and motivate them to implement those practices in their businesses. Each month, Life Science Leader features interviews with executives from the leading pharma and biotech companies, including Pfizer, Merck, Daiichi Sankyo, Genentech, Genzyme, Eli Lilly, and Janssen, as well as the FDA and more. This exclusive thought leadership provides an in-depth look into industry trends and hot topics that will impact the growth … Type: | 5 | 1 | 4 | 4 |
 | Wellington Management Trusted adviser to investors worldwide For almost 100 years, we have chosen to do things differently, including the way we structure our ownership model, organization, and investment platform. Critically, we know that the best investment ideas are found when a diverse workforce is encouraged to bring forward unique perspectives. Wellington Management is one of the world’s largest independent investment management firms, serving as a trusted adviser to over 2,400 clients in more than 60 countries. We manage more than US$1 trillion for pensions, endowments and foundations, insurers, family offices, fund sponsors, global wealth managers, and other clients. As a private … Type: | 3 | 3 | 0 | 3,621 |
 | Otsuka Medical Devices Co., Ltd. Since its establishment in February 2011, Otsuka Medical Devices Co., Ltd. has focused on developing unique solutions that improve the health and well-being of patients whose medical needs and conditions cannot yet be fulfilled by existing treatment methods. To achieve our aspiration of becoming a pioneer in the medical device industry, we combine global R&D efforts with the technology and drug discovery know-how inherent within the Otsuka group’s heritage. Type: | 1 | 1 | 0 | 26 |
 | Science Entrepreneur Club Building communities. Enabling innovation. Connecting the life science ecosystem. We’re a non-profit on a mission to build meaningful communities to enable innovation and connect the life science ecosystem. BioFounder Club Building a start-up is no mean feat and the value of peer-to-peer support cannot be underestimated. So we’ve built a collaborative community exclusively for the founders and C-suite of early-stage life science companies in the UK, now with over 200 members. BioCapital Network Investment in all shapes and sizes is fundamental to growing the life science ecosystem. So we’ve established one of the largest investor communities, with over 300 members … Type: | 14 | 0 | 15 | 35 |
 | Italian Tech Alliance [Automatic translation follows] Formerly VC Hub Italia, it is the association of Venture Capital, investors in innovation, startups and innovative SMEs Italian Tech Alliance is the reference association for: - venture capital funds; - investors in innovation; - innovative startups and SMEs. The objective of the association is to promote the development of the technology and innovation ecosystem in Italy, working closely with institutions. The contents of the Italian Tech Alliance disseminate news, opportunities and interesting reports for private and public stakeholders who work for the economic and social growth of the country. The following currently sit on the Board … Type: | 10 | 4 | 5 | 16 |
 | The Wall Street Journal Winner of 37 Pulitzer Prizes for outstanding journalism, The Wall Street Journal includes coverage of U.S. and world news, politics, arts, culture, lifestyle, sports, health and more. It's a critical resource of curated content in print, online and mobile apps, complete with breaking news streams, interactive features, video, online columns and blogs. Since 1889, readers have trusted the Journal for accurate, objective information to fuel their decisions as well as enlighten, educate and inspire them. On LinkedIn, we will share articles to help you navigate your career, including stories from our business, management, leisure and technology sections. Subscribe: http://on.wsj.com/1n1uvCH Job … Type: | 103 | 51 | 58 | 10,831 |
 | LSX LSX is a growing influential community of senior life science decision makers. We are a catalyst for dialogue, debate and deal making to help lead growth in healthcare investment and the building of billion pound healthcare businesses. We are determined to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare. Our community helps catalyse early stage innovation through peer-to-peer education and knowledge sharing, networking, partnering and deal making to champion the most innovative and exciting ideas. We bring deals to life., LSX is the network for life science executive leaders. Take a … Type: | 30 | 4 | 20 | 5 |
 | EQT Group EQT is a purpose-driven global investment organization EQT is a purpose-driven global investment organization with close to three decades of consistent investment performance across multiple geographies, sectors, and strategies. Type: | 22 | 13 | 9 | 1,291 |
 | Stifel Type: | 13 | 3 | 6 | 6,009 |
 | Media Affairs MediaAffairs entwickelt Wissen über Medienmärkte. Damit unterscheidet sich das Unternehmen wesentlich von konventionellen Anbietern aus dem Bereich der Medien(resonanz)analyse, die – auf gänzlich andere Art und Weise – Daten über Unternehmen, Personen, Themen usw. sammeln und als Informationen über das mediale Geschehen an ihre Kunden übermitteln. Auch MediaAffairs analysiert Medien, erarbeitet Statistiken über Präsenz, Themenführerschaft u.v.m. Darüber hinaus aber kennen wir die Medienmärkte, die wir im Auftrag unserer Kunden beschreiben. Daraus ergibt sich eine einzigartige Expertise unserer Mitarbeiter, mit der diese jede Information über das mediale Geschehen anreichern. Dies ist eine der wesentlichen Voraussetzungen, die uns für den professionellen Dialog … Type: | 82 | 47 | 1 | 16,540 |
NGO, Think-tanks, Ed, & Culture